National Health Act 1953 Amendment determination under paragraph 98C(1)(b) conditions (No. PB 68 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 68 of 2009

Amendment determination under paragraph 98C(1)(b) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 6 July 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — conditions

1              Commencement  

This instrument commences on 1 August 2009.

2              Amendment of PB 119 of 2008

Schedule 1 amends PB 119 of 2008.

Schedule 1            Amendments

[1]     Schedule 1, after item dealing with Mycophenolic Acid with

Water — Purified BP

insert in the columns in the order indicated:

Voriconazole with Water — Purified BP Powder for oral suspension 40 mg per mL, 70 mL

[2]     Schedule 4, after item dealing with Bimatoprost

insert in the columns in the order indicated:

Bimatoprost with timolol Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL

[3]     Schedule 4, item dealing with Glucose Indicator—Blood

omit from the column headed “Form”:

Electrode strips, 100 (TrueSense)

[4]     Schedule 4, after item dealing with Hypromellose in the form Eye drops 5 mg per mL, 15 mL

insert in the column headed “Form”:

Oral gel 20 mg per g, 100 g

[5]     Schedule 4, after item dealing with Ondansetron

insert in the columns in the order indicated:

Oxybutynin Transdermal patches 36 mg, 8

[6]     Schedule 4, after item dealing with Risperidone

insert in the columns in the order indicated:

Rivaroxaban	Tablet 10 mg, 15
Tablet 10 mg, 30

[7]     Schedule 4, after item dealing with Varenicline

insert in the columns in the order indicated:

Voriconazole Powder for oral suspension 40 mg per mL, 70 mL